| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |